{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:03:57Z","timestamp":1784541837970,"version":"3.55.0"},"reference-count":10,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15709","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:12:18Z","timestamp":1781604738000},"page":"1-8","source":"Crossref","is-referenced-by-count":0,"title":["Initial chemotherapy decreases transfusion dependence and enables definitive therapy in metastatic thymoma complicated by pure red cell aplasia: A case report"],"prefix":"10.3892","volume":"32","author":[{"given":"Nobuhito","family":"Hara","sequence":"first","affiliation":[{"name":"Department of Cancer Genomics and Medical Oncology, Nara Medical University, Kashihara, Nara 634\u20118521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Cancer Genomics and Medical Oncology, Nara Medical University, Kashihara, Nara 634\u20118521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Kojitani","sequence":"additional","affiliation":[{"name":"Department of Cancer Genomics and Medical Oncology, Nara Medical University, Kashihara, Nara 634\u20118521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Yoshii","sequence":"additional","affiliation":[{"name":"Department of Cancer Genomics and Medical Oncology, Nara Medical University, Kashihara, Nara 634\u20118521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Ota","sequence":"additional","affiliation":[{"name":"Department of Cancer Genomics and Medical Oncology, Nara Medical University, Kashihara, Nara 634\u20118521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Okazaki","sequence":"additional","affiliation":[{"name":"Department of Cancer Genomics and Medical Oncology, Nara Medical University, Kashihara, Nara 634\u20118521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Ochi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nara Medical University, Kashihara, Nara 634\u20118521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Miyata","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, Nara Medical University, Kashihara, Nara 634\u20118521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsugu","family":"Hamaji","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, Nara Medical University, Kashihara, Nara 634\u20118521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Nara Medical University, Kashihara, Nara 634\u20118521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiko","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Nara Medical University, Kashihara, Nara 634\u20118521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Yoshizawa","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Nara Medical University, Kashihara, Nara 634\u20118521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Cancer Genomics and Medical Oncology, Nara Medical University, Kashihara, Nara 634\u20118521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"key20260720122111_b1-ol-32-2-15709","doi-asserted-by":"publisher","first-page":"S260","DOI":"10.1097\/JTO.0b013e3181f1f62d","article-title":"Epidemiology of thymoma and associated malignancies","volume":"5","author":"Engels","year":"2010","journal-title":"J Thorac Oncol"},{"key":"key20260720122111_b2-ol-32-2-15709","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3324\/haematol.11655","article-title":"Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: A nationwide cohort study in Japan by the PRCA Collaborative Study Group","volume":"93","author":"Hirokawa","year":"2008","journal-title":"Haematologica"},{"key":"key20260720122111_b3-ol-32-2-15709","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s12055-019-00875-2","article-title":"Thymoma associated with pure red cell aplasia: A case report and literature review","volume":"36","author":"Xavier","year":"2020","journal-title":"Indian J Thorac Cardiovasc Surg"},{"key":"key20260720122111_b4-ol-32-2-15709","doi-asserted-by":"publisher","first-page":"759914","DOI":"10.3389\/fmed.2021.759914","article-title":"Pure red cell aplasia and other haematological diseases associated with thymoma: A case series and systematic review","volume":"8","author":"Yen","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"key20260720122111_b5-ol-32-2-15709","doi-asserted-by":"publisher","first-page":"5066","DOI":"10.21037\/jtd.2018.07.14","article-title":"Pure red cell aplasia associated with thymoma: A report of a single-center experience","volume":"10","author":"Moriyama","year":"2018","journal-title":"J Thorac Dis"},{"key":"key20260720122111_b6-ol-32-2-15709","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/1097-0142(19910701)68:1<30::AID-CNCR2820680106>3.0.CO;2-4","article-title":"Chemotherapy for invasive thymoma: A 13-year experience","volume":"68","author":"Fornasiero","year":"1991","journal-title":"Cancer"},{"key":"key20260720122111_b7-ol-32-2-15709","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.lungcan.2021.05.010","article-title":"Management of thymoma associated autoimmune pure red cell aplasia: Case report and systematic review of the literature","volume":"157","author":"Lesire","year":"2021","journal-title":"Lung Cancer"},{"key":"key20260720122111_b8-ol-32-2-15709","doi-asserted-by":"publisher","first-page":"8","DOI":"10.21037\/med.2020.03.01","article-title":"Discrepancy between tumor response and hematologic response in a patient with thymoma and aplastic anemia treated with ciclosporin","volume":"4","author":"Muratori","year":"2020","journal-title":"Mediastinum"},{"key":"key20260720122111_b9-ol-32-2-15709","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1093\/ejcts\/ezu277","article-title":"A meta-analysis of debulking surgery versus surgical biopsy for unresectable thymoma","volume":"47","author":"Hamaji","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"key20260720122111_b10-ol-32-2-15709","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40164-017-0073-6","article-title":"Cyclosporine is a potential curative treatment option for advanced thymoma","volume":"6","author":"Isshiki","year":"2017","journal-title":"Exp Hematol Oncol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T09:21:16Z","timestamp":1784539276000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":10,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6,16]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15709","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]}}}